Trademark: 90627244
Word
INHIBINOL AI
Status
Pending
Status Code
730
Status Date
Thursday, February 22, 2024
Serial Number
90627244
Mark Type
4000
Filing Date
Tuesday, April 6, 2021
Published for Opposition
Tuesday, June 27, 2023

Trademark Owner History
INHIBINOL AI C- CORP - Owner At Publication
Skymount Technologies LLC - Original Applicant

Classifications
5 Nutraceuticals for use as a dietary supplement; pharmaceutical preparations for the treatment of dietary diseases, cardiovascular diseases, disorders and infections, respiratory diseases, disorders and infections, and eye infections; Anti-inflammatory preparations; Anti-inflammatories; Nutraceuticals for the treatment of respiratory and dietary diseases; Antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; botanicals extracts for the treatment of colds and flu; cardiovascular nutraceutical preparations; herbal supplements for the treatment of the respiratory system; nutraceuticals for regulating the immune system; nutraceuticals for the treatment of infectious diseases, namely, respiratory infections, eye infections; nutraceuticals for the treatment of respiratory diseases, disorders and infections; nutraceuticals for the treatment of the respiratory system; nutraceuticals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; nutraceuticals for treating respiratory diseases; nutraceuticals for the treatment of coronavirus diseases and COVID-19; vitamin and mineral preparations for medical use
1 Vitamins for use in the manufacture of nutraceuticals
42 development of pharmaceutical preparations, nutraceuticals, and medicines; pharmaceutical and nutraceutical product development services; research and development of new products for others; drug and nutraceutical product discovery services in the nature of product research; AI-driven development of pharmaceutical preparations, nutraceuticals, and medicines; research and development of pharmaceuticals; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical and nutraceutical product evaluation
"AI"

Trademark Events
Feb 23, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 22, 2024
Sou Extension 1 Granted
Feb 22, 2024
Sou Extension 1 Filed
Feb 22, 2024
Sou Teas Extension Received
Aug 22, 2023
Noa E-Mailed - Sou Required From Applicant
Jun 27, 2023
Official Gazette Publication Confirmation E-Mailed
Jun 27, 2023
Published For Opposition
Jun 7, 2023
Notification Of Notice Of Publication E-Mailed
May 23, 2023
Law Office Publication Review Completed
May 13, 2023
Approved For Pub - Principal Register
Apr 26, 2023
Automatic Update Of Assignment Of Ownership
Mar 16, 2023
Teas/Email Correspondence Entered
Mar 15, 2023
Correspondence Received In Law Office
Mar 15, 2023
Teas Request For Reconsideration Received
Oct 4, 2022
Teas Change Of Correspondence Received
Oct 4, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 4, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 15, 2022
Notification Of Final Refusal Emailed
Sep 15, 2022
Final Refusal E-Mailed
Sep 15, 2022
Final Refusal Written
Jun 17, 2022
Teas/Email Correspondence Entered
Jun 17, 2022
Correspondence Received In Law Office
Jun 16, 2022
Assigned To Lie
Jun 8, 2022
Teas Response To Office Action Received
Dec 8, 2021
Notification Of Non-Final Action E-Mailed
Dec 8, 2021
Non-Final Action E-Mailed
Dec 8, 2021
Non-Final Action Written
Nov 29, 2021
Assigned To Examiner
Jul 15, 2021
New Application Office Supplied Data Entered
Apr 9, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24